After a heart attack, the heart struggles to recoup and maintain energy. One third of patients develop heart failure as a ...
After a heart attack, the heart struggles to recoup and maintain energy. One-third of patients develop heart failure as a ...
Morning Overview on MSN
CRISPR approach targets mitochondria to aid heart failure treatment
Rice University researchers have developed a CRISPR-based gene activation strategy that boosts mitochondrial production in damaged heart cells, improving cardiac function after heart attacks in both ...
Researchers at the Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, and the University of Utah School of Medicine, have demonstrated that a gene therapy can ...
Lower cardiac output has been tied to poorer cerebral blood flow (CBF) in the temporal lobes of older adults without heart failure, a finding that adds to a growing body of research linking heart ...
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...
A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults with heart disease. Harnessing cellular therapies, the company aims to ...
Developing new drugs is one of the riskiest and most expensive endeavors in science. Today, The Jackson Laboratory (JAX) announced a bold initiative to improve that trajectory, powered by an up to $30 ...
Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person’s risk of stroke, heart failure, and even premature death. While many risk factors contribute to A-fib, one stands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results